Updates on Vaccine‐Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
The global burden of acute lower respiratory tract infections, including viral etiologies, equated to 725 557 deaths in 2021 in children under 4 years of age. Community-acquired respiratory viral infections (RVI) also carry a high burden among pediatric solid organ transplant recipients (PSOTR), accounting for 14.5% of hospitalizations in the first year post-transplant in an American cohort. This mini review on behalf of the International Pediatric Transplant Association (IPTA) infectious diseases committee discusses novel preventative and prophylactic strategies and includes pertinent updates for vaccine-preventable RVI including influenza, SARS-CoV-2, and RSV in PSOTR.
Authors
- Hayley A. Gans (ORCID: https://orcid.org/0000-0001-9190-263X)
- Masaki Yamada (ORCID: https://orcid.org/0000-0002-3393-6943)
- Marian G. Michaels (ORCID: https://orcid.org/0000-0002-2556-0544)
- Sanya J. Thomas (ORCID: https://orcid.org/0000-0003-1607-9537)
- Daniel E. Dulek (ORCID: https://orcid.org/0000-0002-1821-6657)
Institutions
- Morgan Stanley Children's Hospital (US)
- University of Pittsburgh (US)
- Monroe Carell Jr. Children's Hospital (US)
- Children's Hospital of Pittsburgh (US)
- National Center For Child Health and Development (JP)
- Stanford Medicine (US)
- Columbia University (US)
- Stanford University (US)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1111/petr.70231
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35